RUA Bioscience (NZX:RUA)
ASX announcement history & article coverage
Transparent by design.
Announcments by RUA Bioscience (NZX:RUA) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Capital Change Notice - Convertible Note
Commencement of direct distribution from Tairawhiti
FY26 Preliminary Financial Results Summary
Rua Bioscience reports 54% revenue growth and stable net loss for FY26, no dividend declared
FY26 Preliminary Financial Results Announcement
Rua Bioscience reports 71% revenue growth and secures major UK export deal in FY26
FY26 Preliminary Financial Results
Rua Bioscience reports increased revenue but sustained losses with going concern risks
Capital Change Notice
Capital Change Notice - Convertible Note
Annual Shareholders’ Meeting and Director Nominations
Rua Bioscience approves Convertible Note Facility
Rua Bioscience approves NZ$600k convertible note facility to boost UK sales growth
Capital Change Notice
NZ Product Approval
Rua Bioscience gains NZ approval for five new medicinal cannabis products
Capital Change Notice
RUA - Trading to resume at market open
Significant UK market expansion through major agreement
Rua Bioscience secures major UK distribution deal worth NZ$10 million
Significant UK market expansion hrough major expansion
Rua Bioscience Limited (“RUA”) – Trading Halt of Securities
Rua Bioscience Limited (“RUA”) – Trading Halt Application
Rua Bioscience Limited (“RUA”) – Trading Halt of Securities